Home » Newsletters » BioWorld Science

BioWorld Science

May 2, 2018

View Archived Issues

European approval recommended for Perjeta as post-surgery treatment of HER2-positive breast cancer

4DMT and Roche expand ophthalmology partnership

Rhopressa launched in the U.S. for lowering intraocular pressure

Trogarzo becomes available in the U.S.

Novel PD-1/GITRL bispecific fusion proteins demonstrate antitumor activity in vivo

Crescendo Biologics completes Series B financing

GlaxoSmithKline reflects on accomplishments of first quarter 2018

Starpharma completes rolling NDA submission for VivaGel BV

MedImmune presents novel bivalent bispecific antibody MEDI-1109

Kodiak Sciences describes KSI-301, an anti-VEGF therapy with extended half-life

Shire offers overview of first quarter 2018

MEN-1611 demonstrates promising in vivo activity in various cancer models

Symphogen initiates first-in-human study of Sym-022 in advanced solid tumors or lymphomas

FDA grants QIDP and fast track designations to oral SCY-078 for vulvovaginal candidiasis

AbbVie submits European MAA for risankizumab in moderate to severe plaque psoriasis

Spark Therapeutics sells priority review voucher to Jazz Pharmaceuticals

FDA approves Kymriah for relapsed or refractory large B-cell lymphoma

DKFZ patents novel KLK6 inhibitors

Genocea files IND for phase I/IIa study of GEN-009

Lactobacillus reuteri may reduce bone loss in older women

Hetero Labs divulges betulinic acid analogues for HIV infection

FDA approves Tafinlar + Mekinist for adjuvant treatment of BRAF V600-mutant melanoma

Actelion seeks FDA approval of Opsumit for inoperable chronic thromboembolic pulmonary hypertension

FDA grants priority review to sBLA for Keytruda

AbbVie presents BRD4 inhibitors

DCB discovers type III TKIs for cancer

Roche reflects on accomplishments of first quarter 2018

Aptevo submits IND for phase I study of APVO-436 in AML and MDS

Exicure reports phase I data on AST-005 in plaque psoriasis

FDA clears Pluristem's IND application for PLX-R18 to treat acute radiation syndrome

Capricor initiates phase II HOPE-2 trial of CAP-1002 in Duchenne muscular dystrophy

FDA grants fast track designation to ACE-083 for facioscapulohumeral muscular dystrophy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...